Market Updates

Lanxess to sell 50% stake in synthetic - Rubber manufacturer Arlanxeo
August, 2018

Recently the speciality chemical group Lanxess, has announced its plans to sell a 50% stake in the synthetic-rubber joint venture (JV) Arlanxeo to its partner Saudi Aramco. The joint venture of these two companies was founded in 2016, now the current value is €3bn.The deal is expected to be complete by the end of this year and subject to approval from the relevant antitrust au [...]

Read More

Trade War Extends, Tension Escalates
August, 2018

On August 3, China announced that it will be imposing retaliatory 25% tariff on LNG from the US. In the official statement, the authorities said, it was retaliatory measure in response to July 10 announcement of 10% tariff on Chinese goods worth $200 billion. The authorities stated the step was taken in light of announcement from Robert Lighthizer, that additional tariff imposition is being considered. The dates of implementation of these tariff imposition is still cleared from both sides.Key Updates -

Read More

Clariant Expands Partnership with Lintech International
August, 2018

In July, Clariant has entered a partnership with Lintech International to exclusively distribute its pigments for the plastics, coating and printing ink industries across the US.Lintech is based in Macon, Georga, and has 14 warehouses across the US. The company has been authorised distributor in the south-eastern, south-western, and western regions for Clariant’s coatings and inks pigments markets for the last five years. Since February 2017, Lintech has been serving as the sole distributor in the US for Clariant Plast [...]

Read More

Trade Tensions Reaches Chemical Industry! What Changed?
August, 2018

Background: Till now much has been written and discussed on the ongoing trade tensions between China and the US. The two sides have been exchanging rhetoric comments and announcing the additional tariff on the imports from other country. Since Donald Trump has taken the Presidency in late 2016, there have been numerous rhetoric exchanges at various fronts for the US. The issues like immigration policies, escalation with North Korea, and recent trade tariff have been the key highlights of this presidency. While all t [...]

Read More

LANXESS to Move Out of Joint Venture
August, 2018

LANXESS and Saudi Aramco formed a joint venture company Arlanxeo in 2016. The firm is one of the leading firm in synthetic rubber manufacturing and is headquartered in Netherlands. Arlanxeo is valued at €3 billion.LANXESS who was a part of this major joint venture is selling its 50% stake to its it’s partner in the joint venture i.e., Saudi Aramco. This proposal is waiting for the approval of antitrust authorities and is expected to be completed by end of 2018.

Read More

Food preservative – boon or bane?
August, 2018

Food preservatives chemicals such as benzoic acid, nitrites, and sulphites, utilised as an additive to increase the shelf life of a product. Food preservatives has posi [...]

Read More

Novartis-Avexis: An Acquisition Deal for $8.7 billion
August, 2018

Novartis-Avexis: An Acquisition Deal for $8.7 billionGene therapy is a novel treatment method, that involves the introduction of genetic material or gene as therapeutic molecules using a viral vector carrier. Based on the therapeutic approach, the oligonucleotide sequence is either integrated into the chromosome or is expressed within the cell. The concept of gene therapy ascended during the 1960s and 1970s and was first tried over two decades ago on four-year-old girl who has congenital disease [...]

Read More

5 Major Lung Disease Developments of 2017
August, 2018

Pulmonary medicine is the branch of medical science that deals with diagnosis, prevention, and treatment of diseases affecting the respiratory system. The conditions included are acute respiratory distress syndrome, sarcoidosis of the lungs, asthma, chronic obstructive pulmonary disease, lung cancer, occupational lung disease, pulmonary hypertension, tuberculosis, cystic fibrosis, interstitial lung disease, lung transplants, and severe acute respiratory syndrome.The top 5 clinical trials and other developments in lung diseas [...]

Read More

Opioid Pain-killer Oxycodone ER rejected by FDA
August, 2018

Intellipharmaceutics’ opioid painkiller Oxycodone ER has had approval withheld by the FDA, which has requested further information on its abuse-deterrent properties. The company responded to the Complete Response Letter (CRL) from the FDA by stating the judgement was in line with its plans for the drug, formerly known as Rexista. FDA sited Intellipharmaceutics complete relevant Category 2 and Category 3 studies to assess the abuse-deterrent properties of Oxycodone ER by the oral and nasal routes of administration.The F [...]

Read More

Top 10 2018: A look at the world’s expected 10 largest medical devices companies
August, 2018

The medical device market is one the major industries in healthcare and is one of the rapidly growing field within life sciences, with continuous advancement and new technologies. The market has numerous products that vary from medical gloves to prosthesis to diagnostic impaging equipment, along with the development of emerging technologies that offers improved clinical outcome. The market consists of comparatively small number of giant players and huge number of small players that are involved in R&D of advanced devices. The global med [...]

Read More